Literature DB >> 15684121

Liver enzyme alteration: a guide for clinicians.

Edoardo G Giannini1, Roberto Testa, Vincenzo Savarino.   

Abstract

Isolated alterations of biochemical markers of liver damage in a seemingly healthy patient can present a challenge for the clinician. In this review we provide a guide to interpreting alterations to liver enzyme levels. The functional anatomy of the liver and pathophysiology of liver enzyme alteration are briefly reviewed. Using a schematic approach that classifies enzyme alterations as predominantly hepatocellular or predominantly cholestatic, we review abnormal enzymatic activity within the 2 subgroups, the most common causes of enzyme alteration and suggested initial investigations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15684121      PMCID: PMC545762          DOI: 10.1503/cmaj.1040752

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  81 in total

Review 1.  Evaluation of abnormal liver-enzyme results in asymptomatic patients.

Authors:  D S Pratt; M M Kaplan
Journal:  N Engl J Med       Date:  2000-04-27       Impact factor: 91.245

Review 2.  Abnormal findings on liver function tests. Interpreting results to narrow the diagnosis and establish a prognosis.

Authors:  D V Gopal; H R Rosen
Journal:  Postgrad Med       Date:  2000-02       Impact factor: 3.840

Review 3.  Genetic liver disease in adults. Early recognition of the three most common causes.

Authors:  E D Morrison; K V Kowdley
Journal:  Postgrad Med       Date:  2000-02       Impact factor: 3.840

4.  Effect of hospitalisation on liver enzymes in healthy subjects.

Authors:  H Narjes; G Nehmiz
Journal:  Eur J Clin Pharmacol       Date:  2000-07       Impact factor: 2.953

Review 5.  Aminotransferases in disease.

Authors:  R Rej
Journal:  Clin Lab Med       Date:  1989-12       Impact factor: 1.935

Review 6.  Alkaline phosphatase isozymes: recent progress.

Authors:  W H Fishman
Journal:  Clin Biochem       Date:  1990-04       Impact factor: 3.281

Review 7.  Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests.

Authors:  D R Dufour; J A Lott; F S Nolte; D R Gretch; R S Koff; L B Seeff
Journal:  Clin Chem       Date:  2000-12       Impact factor: 8.327

8.  A revised natural history model for primary sclerosing cholangitis.

Authors:  W R Kim; T M Therneau; R H Wiesner; J J Poterucha; J T Benson; M Malinchoc; N F LaRusso; K D Lindor; E R Dickson
Journal:  Mayo Clin Proc       Date:  2000-07       Impact factor: 7.616

9.  Ischemic hepatitis: clinical presentation and pathogenesis.

Authors:  R K Seeto; B Fenn; D C Rockey
Journal:  Am J Med       Date:  2000-08-01       Impact factor: 4.965

10.  The temporal profile of increased transaminase levels in patients with acetaminophen-induced liver dysfunction.

Authors:  A J Singer; T R Carracio; H C Mofenson
Journal:  Ann Emerg Med       Date:  1995-07       Impact factor: 5.721

View more
  372 in total

1.  Future prospects for biomarkers of alcohol consumption and alcohol-induced disorders.

Authors:  Willard M Freeman; Kent E Vrana
Journal:  Alcohol Clin Exp Res       Date:  2010-04-05       Impact factor: 3.455

2.  Mellow Yellow: Diagnosis and Management of Multifactorial Postoperative Jaundice.

Authors:  Apurva Tandon; Andrew K Roorda; Prithvi Legha; Ankur Sangoi; George Triadafilopoulos
Journal:  Dig Dis Sci       Date:  2015-10-30       Impact factor: 3.199

Review 3.  Best practice in primary care pathology: review 5.

Authors:  W S A Smellie; J Forth; S Ryder; M J Galloway; A C Wood; I D Watson
Journal:  J Clin Pathol       Date:  2006-04-27       Impact factor: 3.411

4.  The effects of melatonin on liver functions in arsenic-induced liver damage.

Authors:  İlhan Bali; Bülent Bilir; Seyfi Emir; Filiz Turan; Ahsen Yılmaz; Tuba Gökkuş; Murat Aydın
Journal:  Ulus Cerrahi Derg       Date:  2016-10-27

5.  Alkaline phosphatase and percentage body fat predict circulating C-reactive protein in premenopausal women.

Authors:  Fatima Nayeem; Karl E Anderson; Manubai Nagamani; James J Grady; Lee-Jane W Lu
Journal:  Biomarkers       Date:  2010-09-29       Impact factor: 2.658

6.  Liver injury and abscess formation in secondary murine peritonitis.

Authors:  Andreas M Lenz; Mark Fairweather; James C Peyton; Sarah A Gardner; William G Cheadle
Journal:  Inflamm Res       Date:  2010-10-26       Impact factor: 4.575

Review 7.  Blood-Bile Barrier: Morphology, Regulation, and Pathophysiology.

Authors:  Tirthadipa Pradhan-Sundd; Satdarshan Pal Monga
Journal:  Gene Expr       Date:  2019-01-15

8.  The impact of diet-induced hepatic steatosis in a murine model of hepatic ischemia/reperfusion injury.

Authors:  Kim H H Liss; Kyle S McCommis; Kari T Chambers; Terri A Pietka; George G Schweitzer; Sara L Park; Ilke Nalbantoglu; Carla J Weinheimer; Angela M Hall; Brian N Finck
Journal:  Liver Transpl       Date:  2018-07       Impact factor: 5.799

9.  Efavirenz concentrations in HIV-infected patients with and without viral hepatitis.

Authors:  Sofia A Pereira; Umbelina Caixas; Teresa Branco; Isabel Germano; Fátima Lampreia; Ana L Papoila; Emília C Monteiro
Journal:  Br J Clin Pharmacol       Date:  2008-06-09       Impact factor: 4.335

10.  Liver function tests in patients with bacteremia.

Authors:  Shinichiro Kanai; Takayuki Honda; Takeshi Uehara; Takehisa Matsumoto
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.